CLDN1 and serum lipopolysaccharide activity: It resulted in the reduction of endotoxemia (through LPSs) and pro-inflammatory cytokine (TNF-α, IL-6, and IL-1β) levels, with the increased expression of tight-junction associated proteins (claudin-1, occludin, and zonula occludens-1).